Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Cytoreduction Surgical Procedures × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 22 Peritoneal Neoplasms 16 Fallopian Tube Neoplasms 10 Colorectal Neoplasms 7 Carcinoma, Ovarian Epithelial 6 Stomach Neoplasms 5 Neoplasms 3 Hyperthermia 3 Gastrointestinal Neoplasms 3 Colonic Neoplasms 3 Appendiceal Neoplasms 3 Adrenocortical Carcinoma 3 Sarcoma 2 Rhabdomyosarcoma 2 Mesothelioma, Malignant 2 Glioma 2 Glioblastoma 2 Desmoplastic Small Round Cell Tumor 2 Carcinoma 2 Brain Neoplasms 2 Adenoma, Islet Cell 2 Wilms Tumor 1 Retroperitoneal Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Pseudomyxoma Peritonei 1 Pleural Effusion, Malignant 1 Peritoneal Cavity Cancer 1 Peritoneal Cancer 1 Pelvic Neoplasms 1

Interventions

Sorafenib 203 lenvatinib 129 Bevacizumab 106 Nivolumab 75 atezolizumab 67 pembrolizumab 66 Radiosurgery 58 durvalumab 57 Oxaliplatin 54 Fluorouracil 52 sintilimab 48 Doxorubicin 43 apatinib 41 Hepatectomy 39 tislelizumab 38 camrelizumab 37 Radiofrequency Ablation 36 Leucovorin 36 tremelimumab 34 Radiotherapy 34 Magnetic Resonance Spectroscopy 31 Immune Checkpoint Inhibitors 27 Folfox protocol 26 regorafenib 25 Cyclophosphamide 25 Cisplatin 25 Capecitabine 25 cabozantinib 23 Ipilimumab 23 Gemcitabine 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00820157 2013-08-13

TACE

Eastern Hepatobiliary Surgery Hospital

Phase NA Completed

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡